CorMedix (CRMD) Other Non-Current Assets (2010 - 2025)
CorMedix (CRMD) reported Other Non-Current Assets of $642066.0 for Q2 2025, up 514.85% on a YoY basis from $104426.0 in Q2 2024, and little changed sequentially from $642066.0 in Q1 2025.
CorMedix (CRMD) Other Non-Current Assets (2010 - 2025) Analysis & Trends
CorMedix (CRMD) has 15 years of Other Non-Current Assets data on file, last reported at $642066.0 in Q2 2025.
- For the quarter ending Q2 2025, Other Non-Current Assets rose 514.85% year-over-year to $642066.0; the trailing twelve-month figure through Jun 2025 stood at $642066.0 (up 514.85% YoY), and the FY2024 full-year result was $105368.0, up 36.84% from the prior year.
- Other Non-Current Assets held at $642066.0 in Q2 2025, from $642066.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $642066.0 in Q1 2025 to a low of $77000.0 in Q4 2023.
- A 5-year average of $170214.0 and a median of $105226.0 in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets sank 73.24% in 2021 and soared 518.33% in 2025, its largest moves.
- Tracing CRMD's Other Non-Current Assets over 5 years: stood at $102305.0 in 2021, then grew by 0.01% to $102320.0 in 2022, then slipped by 24.75% to $77000.0 in 2023, then soared by 36.84% to $105368.0 in 2024, then surged by 509.36% to $642066.0 in 2025.
- Business Quant data shows CRMD's Other Non-Current Assets at $642066.0 in Q2 2025, $642066.0 in Q1 2025, and $105368.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 642,066.00 |
| Mar 31, 2025 | 642,066.00 |
| Dec 31, 2024 | 105,368.00 |
| Sep 30, 2024 | 105,084.00 |
| Jun 30, 2024 | 104,426.00 |
| Mar 31, 2024 | 103,838.00 |
| Dec 31, 2023 | 77,000.00 |
| Sep 30, 2023 | 102,664.00 |
| Jun 30, 2023 | 102,370.00 |
| Mar 31, 2023 | 102,345.00 |
| Dec 31, 2022 | 102,320.00 |
| Sep 30, 2022 | 114,000.00 |
| Jun 30, 2022 | 121,000.00 |
| Mar 31, 2022 | 129,000.00 |
| Dec 31, 2021 | 102,305.00 |
| Sep 30, 2021 | 134,000.00 |
| Jun 30, 2021 | 138,000.00 |
| Mar 31, 2021 | 136,000.00 |
| Dec 31, 2020 | 191,000.00 |
| Sep 30, 2020 | 500,822.00 |